AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Esophageal Pre-Cancer Testing Gaining Greater Traction
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
Genetic Predisposition to Stress Fractures ID’d in Healthy Individuals
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
States Eye Expanding Roadside Drug Tests as Law Enforcement Implements Oral Fluid Testing Pilots
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Cotesting Best for Cervical Cancer Screening, But Cytology Doesn’t ID Other Gynecological Cancers
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Low Histopathologic Agreement for DCIS, Atypia Breast Cancer
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…
At-Home Testing Company Cor Crowdfunding for Commercialization
From - Diagnostic Testing & Emerging Technologies
At-home testing company Cor (San Francisco) has taken to online crowdfunding to commercialize its blood chemistry device. As of April 6, the company had pledges on…
TAPUR Study Launches to Evaluate Off-Label Uses of Targeted Cancer Therapies
From - Diagnostic Testing & Emerging Technologies
The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by …
ACMG Studies Provide Lessons in Genetic Test Ordering Management
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here